MR Spectroscopy-derived Proton Density Fat Fraction Is Superior to Controlled Attenuation Parameter for Detecting and Grading Hepatic Steatosis.
暂无分享,去创建一个
Jaap Stoker | J. Stoker | A. Nederveen | U. Beuers | J. Verheij | S. Kuiken | J. Runge | Joanne Verheij | Ulrich Beuers | L. P. Smits | Jurgen Henk Runge | Loek Pieter Smits | Annekatrien Depla | Sjoerd Douwe Kuiken | Bert Cornelis Baak | Aart Johannes Nederveen | A. Depla | B. Baak | L. Smits
[1] A. Pollett,et al. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography , 2012, Liver international : official journal of the International Association for the Study of the Liver.
[2] Patrice Cacoub,et al. Meta-analyses of FibroTest diagnostic value in chronic liver disease , 2007, BMC gastroenterology.
[3] F. Oberti,et al. Learning curve and interobserver reproducibility evaluation of liver stiffness measurement by transient elastography: , 2017 .
[4] E. Yoshida,et al. Patient preference and willingness to pay for transient elastography versus liver biopsy: A perspective from British Columbia. , 2015, Canadian journal of gastroenterology & hepatology.
[5] Joan Tordjman,et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients , 2012, Hepatology.
[6] Tanya Wolfson,et al. Reproducibility of MR‐based liver fat quantification across field strength: Same‐day comparison between 1.5T and 3T in obese subjects , 2015, Journal of magnetic resonance imaging : JMRI.
[7] J. Hoogduin,et al. Reproducibility of 3.0 Tesla magnetic resonance spectroscopy for measuring hepatic fat content , 2009, Journal of magnetic resonance imaging : JMRI.
[8] T. Berg,et al. Non-Invasive Assessment of Hepatic Steatosis in Patients with NAFLD Using Controlled Attenuation Parameter and 1H-MR Spectroscopy , 2014, PloS one.
[9] Li Ying,et al. Controlled attenuation parameter for the detection of steatosis severity in chronic liver disease: A meta‐analysis of diagnostic accuracy , 2014, Journal of gastroenterology and hepatology.
[10] Dario Conte,et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease , 2007, Gut.
[11] J. Vergniol,et al. Non‐invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography , 2012, Liver international : official journal of the International Association for the Study of the Liver.
[12] T. Yamanaka,et al. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography. , 2016, Gastroenterology.
[13] A. Gamst,et al. Reproducibility of MRI‐determined proton density fat fraction across two different MR scanner platforms , 2011, Journal of magnetic resonance imaging : JMRI.
[14] R. Idilman,et al. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. , 2013, Radiology.
[15] J. Stoker,et al. Quantitative determination of liver triglyceride levels with 3T ¹H-MR spectroscopy in mice with moderately elevated liver fat content. , 2014, Academic radiology.
[16] M. Ziol,et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. , 2003, Ultrasound in medicine & biology.
[17] G. Bedogni,et al. Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution , 2013, Hepatology.
[18] J. Stoker,et al. Noninvasive Differentiation between Hepatic Steatosis and Steatohepatitis with MR Imaging Enhanced with USPIOs in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study. , 2016, Radiology.
[19] E. Cholongitas,et al. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. , 2011, Journal of hepatology.
[20] S. Grundy,et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. , 2005, American journal of physiology. Endocrinology and metabolism.
[21] Brian W. Anthony,et al. Quantitative Hepatic Fat Quantification in Non-alcoholic Fatty Liver Disease Using Ultrasound-Based Techniques: A Review of Literature and Their Diagnostic Performance. , 2018, Ultrasound in medicine & biology.
[22] Paul Calès,et al. Sources of variability in histological scoring of chronic viral hepatitis , 2005, Hepatology.
[23] B. Neuschwander‐Tetri,et al. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings , 2011, Hepatology.
[24] M. Friedrich-Rust,et al. Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis , 2010, BMC gastroenterology.
[25] A. Gamst,et al. Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. , 2015, Radiology.
[26] A. Gamst,et al. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. , 2013, Radiology.
[27] B. Bell,et al. A comparison of hepatopathologists' and community pathologists' review of liver biopsy specimens from patients with hepatitis C. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[28] S. Reeder,et al. Validation of MRI biomarkers of hepatic steatosis in the presence of iron overload in the ob/ob mouse , 2012, Journal of magnetic resonance imaging : JMRI.
[29] V. de Lédinghen,et al. Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. , 2010, Ultrasound in medicine & biology.
[30] Rohit Loomba,et al. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials , 2013, Hepatology.
[31] Mithat Gönen,et al. Quantitative imaging biomarkers: A review of statistical methods for technical performance assessment , 2015, Statistical methods in medical research.
[32] J. Hanley,et al. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. , 1983, Radiology.
[33] J. Stoker,et al. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis , 2010, European Radiology.